Found: 12
Select item for more details and to access through your institution.
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 832, doi. 10.1111/dom.14932
- By:
- Publication type:
- Article
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 266, doi. 10.1111/dom.12814
- By:
- Publication type:
- Article
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.
- Published in:
- Drugs, 2020, v. 80, n. 10, p. 995, doi. 10.1007/s40265-020-01323-x
- By:
- Publication type:
- Article
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 19, p. 1553, doi. 10.1093/eurheartj/ehz059
- By:
- Publication type:
- Article
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial.
- Published in:
- Journal of Arrhythmia, 2018, v. 34, n. 2, p. 148, doi. 10.1002/joa3.12024
- By:
- Publication type:
- Article
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1797, doi. 10.1002/ejhf.2982
- By:
- Publication type:
- Article
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 10, p. 1412, doi. 10.1093/eurjpc/zwac033
- By:
- Publication type:
- Article
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
- Published in:
- Clinical Cardiology, 2021, v. 44, n. 7, p. 1002, doi. 10.1002/clc.23649
- By:
- Publication type:
- Article
Uninterrupted anticoagulation with non‐vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 1, p. 198, doi. 10.1002/clc.23120
- By:
- Publication type:
- Article
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2024, v. 15, n. 1, p. 412, doi. 10.1002/jcsm.13393
- By:
- Publication type:
- Article